All News

Overall cancer death rates have continued to decline in the U.S. among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including prostate cancer, a recent national report shows.

The third and most recent update of the Partin tables takes into account an updated Gleason scoring system and may be more accurate for contemporary patients diagnosed with prostate cancer, researchers from Johns Hopkins University, Baltimore report.

Researchers at Dana-Farber Cancer Institute, Boston, have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones.

Patients who have inherited a specific common genetic variant develop bladder cancer tumors that strongly express a protein known as prostate stem cell antigen (PSCA), which is also expressed in many prostate and pancreatic tumors, say researchers from the National Cancer Institute, Bethesda, MD.

Abbott Laboratories has announced FDA clearance of a new testosterone test designed to accurately measure a wide range of testosterone levels seen in both men and women.

Online reviews of urologists tend to be positive, but this consensus is generally composed of only two or three patient scores per physician, researchers report.

Among rescue and recovery workers exposed to dust, debris, and fumes following the World Trade Center terrorist attack, there was an increased incidence of prostate and thyroid cancers and multiple myeloma, although it is not clear how big a factor medical screening and non-WTC risk factors contributed to these increases, according to a recent study.

Two new studies shed light on recent trends in prostate cancer screening.One study found that prostate cancer screening in men older than 74 years of age is overused, while another documented a decline in prostate and other preventive cancer screenings over the last 10 years, possibly due to disagreement over current screening guidelines.

Patients with muscle-invasive bladder cancer who undergo robot-assisted radical cystectomy may experience less blood loss and shorter hospital stays than those undergoing open cystectomy, results of a new randomized study indicate.

If least costly alternative (LCA) policies for certain prostate cancer drugs had not been rescinded in 2010, Medicare expenditures would have been reduced by more than $33 million over 1 year, a new government report suggests.

Medical expulsive therapy for the initial management of uncomplicated acute renal colic, with eventual uretereoscopy if needed, is associated with less resource utilization and lower 6-week costs than early surgery, say researchers from the University of Michigan, Ann Arbor.

Urology Product Preview

Drugs and devices in the pipeline from Auxilium Pharmaceuticals, Inc., Nymox Pharmaceutical Corp., Palatin Technologies, Inc., ProUroCare Medical Inc., Bioniche Life Sciences Inc., Tengion Inc., Aeterna Zentaris Inc., and Can-Fite BioPharma.

Sifting through the data that came out of Urology Times' recently released "State of the Specialty" survey, it's clear that the issues most concerning to urologists relate to the business side of practicing medicine.

The latest products and services from Coloplast, Galt Medical (Theragenics Corp.), the Medical Group Management Association, SullivanLuallin, Accuray Inc., the Simon Foundation for Continence, Varian Medical Systems, FAIR Health, Patient Point, UroMed, Cure Medical, and Three Ten LLC.

One of the elements in the Patient Protection and Affordable Care Act that may affect urologists is the Physician Payment Sunshine Provision, which requires drug and medical device manufacturers to publicly report gifts and payments made to physicians and teaching hospitals beginning in 2013.

Insertion of a ureteral access sheath during retrograde intra-renal surgery may induce severe ureteric injuries, according to a prospective analysis of 136 patients undergoing procedures using ureteral access sheaths.